CIBC World Market
PNT

CIBC World Market’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

CIBC World Market’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-70,645
Closed -$471K – 1329
2023
Q3 		$471K Buy
+70,645
New +$587K ﹤0.01% 914
2023
Q1 		– Sell
-12,250
Closed -$89K – 1365
2022
Q4 		$89K Hold
12,250
– – ﹤0.01% 1204
2022
Q3 		$95K Hold
12,250
– – ﹤0.01% 1182
2022
Q2 		$83K Hold
12,250
– – ﹤0.01% 1208
2022
Q1 		$98K Buy
+12,250
New +$77.8K ﹤0.01% 1252

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CIBC World Market's PNT Position: Q4 2023 in Review

CIBC World Market sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 70,645 shares — an estimated $471K sold.

CIBC World Market first reported a position in PNT in Q1 2022 and held it in 5 quarters. The position peaked at $471K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • CIBC World Market reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • CIBC World Market sold 70,645 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $471K.
  • CIBC World Market first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • CIBC World Market's POINT Biopharma Global Inc. Common Stock position peaked at $471K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on CIBC World Market's 13F filing for Q4 2023, filed 13 Feb 2024.